The gene-editing tool has been used in a trial to enhance the blood cells of two patients with cancer, according to NPR.
No comments yet. Be the first to comment!
Users invited can see your content
- NPR.org (2018)
- Scientific American (2018)
- Vox (2019)
(2019)
- POZ (2021)
(2021)
- Youtube - TED-Ed (2022)
- STAT (2017)
- YouTube - TED (2023)
- YouTube - The Well (2023)
- MIT Technology Review (2023)
- The Economist (2023)
Related chunks with this resource
No comments yet. Be the first to comment!